Literature DB >> 22043778

Acute hematogenous osteomyelitis and septic arthritis in children: clinical characteristics and outcomes study.

Pisit Sukswai1, Dool Kovitvanitcha, Veerasak Thumkunanon, Tawee Chotpitayasunondh, Varaporn Sangtawesin, Yongyot Jeerathanyasakun.   

Abstract

OBJECTIVE: To evaluate the clinical features, causative pathogens and outcomes-related to acute hematogenous osteomyelitis and septic arthritis in pediatric patients. MATERIAL AND
METHOD: The authors conducted a retrospective cohort study of patients under 15 years of age with diagnosis of acute hematogenous osteomyelitis (AHO) and/or septic arthritis (SA), treated at Queen Sirikit National Institute of Child Health from 1996 to 2006. Demographic data, clinical characteristics, bacterial spectrum, and outcomes were collected. Potential risk factors for osteoarticular sequelae in the patients who had more than 2 years of follow-up were analyzed.
RESULTS: One hundred and twenty-nine patients met the diagnostic criteria which included 51 cases with SA, 35 cases with AHO and 37 cases with both SA and AHO. The patient's age ranged between 1 day and 13 years 4 months, comprising 37 (28.6%) of newborns, 28 (21.7%) of > 1-12 months, 18 (14%) of > 1-3 years and 46 (35.7%) of > 3-15 years. Causative bacteria were found in 103 of 129 patients (80%), the two most common pathogens were methicillin-sensitive Staphylococcus aureus (MSSA) in 48 (46.6%) and methicillin-resistant Staphylococcus aureus (MRSA) in 18 (17.5%) cases. The initial temperature on admission day was high (> 37.5 degrees C) in only one-third of newborns, one-half of infants and two-thirds of the older group. The duration of antibiotic administration ranged between 21 and 56 days (mean 42 days). Arthrotomy or drainage and bone or joint aspiration underwent in 62% and 17% of cases respectively. Outcomes of 79 patients who had more than 2 years of follow-up identified osteoarticular sequelae in 23 patients (29%) that consisted of avascular necrosis of epiphysis, limb-length discrepancy and pathologic fractures. Univariate analysis for potential risk factors compared between sequelae and without sequelae groups demonstrated significant association with more than 1 week duration of presenting symptoms, newborn age group, hip joint infection, infection with MRSA and more than 3 days delayed treatment with appropriate antibiotics.
CONCLUSION: MSSA was the most common bacterial pathogen causing pediatric osteoarticular infections in all age groups but was second to MRSA in the newborn group. Osteoarticular sequelae were avascular necrosis of epiphysis, limb length discrepancy, and pathologic fracture which were significantly related to longer duration of presenting symptoms, newborn age group, hip joint involvement, MRSA infection and delayed administration of appropriate antibiotics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22043778

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  11 in total

1.  Septic arthritis of the hip and knee treated surgically in pediatric patients: Analysis of the Kids' Inpatient Database.

Authors:  Mikhail Tretiakov; Frank S Cautela; Sarah E Walker; Joanne C Dekis; George A Beyer; Jared M Newman; Neil V Shah; Jenna Borrelli; Sharan T Shah; Anter S Gonzales; Jennifer M Cushman; John P Reilly; Jeffrey M Schwartz; Claude B Scott; Khalid Hesham
Journal:  J Orthop       Date:  2019-01-04

Review 2.  Global epidemiology of childhood bone and joint infection: a systematic review.

Authors:  Sarah Hunter; Heidi Chan; Joseph F Baker
Journal:  Infection       Date:  2022-01-20       Impact factor: 3.553

Review 3.  Neonatal osteomyelitis: an Italian multicentre report of 22 cases and comparison with the inherent literature.

Authors:  Marco Roversi; Elena Chiappini; Renato Maria Toniolo; Marco Cirillo; Fabio Natale; Daniele Deriu; Annalisa Grandin; Laura Lancella; Luisa Galli; Alberto Villani; Andrzej Krzysztofiak
Journal:  J Perinatol       Date:  2021-03-08       Impact factor: 3.225

4.  The epidemiology of pediatric bone and joint infections in Cambodia, 2007-11.

Authors:  Nicole Stoesser; Joanna Pocock; Catrin E Moore; Sona Soeng; PutChhat Hor; Poda Sar; Direk Limmathurotsakul; Nicholas Day; Varun Kumar; Sophy Khan; Vuthy Sar; Christopher M Parry
Journal:  J Trop Pediatr       Date:  2012-09-13       Impact factor: 1.165

5.  Clinical and epidemiological characteristics of septic arthritis of the hip, 2006 to 2012, a seven-year review.

Authors:  Helder de Souza Miyahara; Camilo Partezani Helito; Guilherme Batista Oliva; Paulo César Aita; Alberto Tesconi Croci; José Ricardo Negreiros Vicente
Journal:  Clinics (Sao Paulo)       Date:  2014-07       Impact factor: 2.365

6.  Procalcitonin and Pancreatic Stone Protein Function as Biomarkers in Early Diagnosis of Pediatric Acute Osteomyelitis.

Authors:  Chunmiao Cui; Muyong Fu; Boqian Gao
Journal:  Med Sci Monit       Date:  2017-11-01

7.  Epidemiology and Management of Acute Haematogenous Osteomyelitis in a Tertiary Paediatric Center.

Authors:  Elena Chiappini; Caterina Camposampiero; Simone Lazzeri; Giuseppe Indolfi; Maurizio De Martino; Luisa Galli
Journal:  Int J Environ Res Public Health       Date:  2017-05-04       Impact factor: 3.390

8.  The Limping Child, a Rare Differential: Pyomyositis of the Iliacus Muscle -A Case Report.

Authors:  Ethan Toner; Ahmad Khaled; Yacoob Nakhuda; Randeep Mohil
Journal:  J Orthop Case Rep       Date:  2019

9.  Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis.

Authors:  Andrzej Krzysztofiak; Marco Roversi; Antonio Musolino; Marco Cirillo; Renato Maria Toniolo; Osvaldo Mazza; Livia Gargiullo; Laura Lancella; Paolo Rossi; Alberto Villani
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

10.  Contemporary Clinical Isolates of Staphylococcus aureus from Pediatric Osteomyelitis Patients Display Unique Characteristics in a Mouse Model of Hematogenous Osteomyelitis.

Authors:  Philip M Roper; Kara R Eichelberger; Linda Cox; Luke O'Connor; Christine Shao; Caleb A Ford; Stephanie A Fritz; James E Cassat; Deborah J Veis
Journal:  Infect Immun       Date:  2021-06-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.